Epstein Secrets

idance, Americans' confidence in those agencies and the vaccine process dropped. But now indications that confidence is slowly starting to return. A Gallup poll finds 58 percent are now likely to be vaccinated, up from a low of 50 percent in September, though 42 percent still say they won't get the vacc

ted by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behi

dance, Americans' confidence in those agencies and the vaccine process dropped. But now indications that confidence is slowly starting to return. A Gallup poll finds 58 percent are now likely to be vaccinated, up from a low of 50 percent in September, though 42 percent still say they won't get the vac

ed by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behin

e country took to the streets on Monday to demand that science and health concerns rule decisions about when and how to resume in-person learning." Gallup Finds Partisan Divide Over Reopening Schools. The Washington Times (8/4, Harper, 492K) reports that a new Gallup poll reveals "a distinct partisan d

at's got to rest with physicians and patients." Novavax Reports Positive Results For Vaccine Candidate. The New York Times (8/4, 18.61M) reports, "Novavax, the little-known Maryland company that received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine, announce